Financials Xplus Inc.

Equities

A373200

KR7373200005

Commodity Chemicals

End-of-day quote Korea S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
1,525 KRW +10.75% Intraday chart for Xplus Inc. +19.14% -15.63%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 8,360 94,231
Enterprise Value (EV) 1 2,966 104,274
P/E ratio 14.6 x -21.7 x
Yield - 0.94%
Capitalization / Revenue 0.59 x 5.72 x
EV / Revenue 0.21 x 6.33 x
EV / EBITDA 1 x 768 x
EV / FCF - -4,781,689 x
FCF Yield - -0%
Price to Book 1.12 x 6.96 x
Nbr of stocks (in thousands) 14,080 70,585
Reference price 2 593.8 1,335
Announcement Date 3/23/23 3/23/23
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022
Net sales 1 14,103 16,485
EBITDA 1 2,977 135.8
EBIT 1 2,830 -77.05
Operating Margin 20.06% -0.47%
Earnings before Tax (EBT) 1 2,857 -4,449
Net income 1 2,305 -4,517
Net margin 16.35% -27.4%
EPS 2 40.75 -61.64
Free Cash Flow - -21,807
FCF margin - -132.28%
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - 12.50
Announcement Date 3/23/23 3/23/23
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022
Net Debt 1 - 10,043
Net Cash position 1 5,394 -
Leverage (Debt/EBITDA) - 73.97 x
Free Cash Flow - -21,807
ROE (net income / shareholders' equity) - -41.2%
ROA (Net income/ Total Assets) - -0.25%
Assets 1 - 1,824,291
Book Value Per Share 2 530.0 192.0
Cash Flow per Share 2 319.0 17.10
Capex 1 958 20,526
Capex / Sales 6.79% 124.51%
Announcement Date 3/23/23 3/23/23
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW